AdvisorShares Psychedelics ETF (PSIL)

NYSEARCA: PSIL · Real-Time Price · USD
19.36
-1.27 (-6.17%)
Oct 10, 2025, 2:53 PM EDT - Market open
-6.17%
Assets$19.02M
Expense Ratio0.99%
PE Ration/a
Shares Out954,976
Dividend (ttm)$0.25
Dividend Yield1.29%
Ex-Dividend DateSep 22, 2025
Payout FrequencyQuarterly
Payout Ration/a
Volume46,808
Open20.64
Previous Close20.64
Day's Range19.09 - 20.64
52-Week Low7.14
52-Week High20.74
Beta0.93
Holdings29
Inception DateSep 15, 2021

About PSIL

Fund Home Page

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is issued by AdvisorShares.

Asset Class Equity
Category Miscellaneous Sector
Stock Exchange NYSEARCA
Ticker Symbol PSIL
ETF Provider AdvisorShares

Top 10 Holdings

69.61% of assets
NameSymbolWeight
Atai Life Sciences N.V.ATAI15.35%
Mind Medicine (MindMed) Inc.MNMD8.47%
COMPASS Pathways plcCMPS8.33%
NRx Pharmaceuticals, Inc.NRXP7.05%
Neuphoria Therapeutics Inc.NEUP5.85%
Vistagen Therapeutics, Inc.VTGN5.13%
Supernus Pharmaceuticals, Inc.SUPN4.99%
Alkermes plcALKS4.94%
Neurocrine Biosciences, Inc.NBIX4.81%
Relmada Therapeutics, Inc.RLMD4.67%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Sep 22, 2025$0.0201Sep 29, 2025
Jun 23, 2025$0.0119Jun 27, 2025
Mar 21, 2025$0.16343Mar 28, 2025
Dec 23, 2024$0.0548Dec 30, 2024
Sep 23, 2024$0.1087Sep 30, 2024
Sep 25, 2023$0.0336Sep 29, 2023
Full Dividend History

Performance

PSIL had a total return of 176.46% in the past year, including dividends. Since the fund's inception, the average annual return has been -32.11%.

News

This Psychedelics ETF Has Investors Going Crazy (In a Good Way)

When it comes to curing common ailments, the majority of doctors won't be prescribing things like LSD, mescaline, PCP, or psilocybin (mushrooms) anytime soon. But these are examples of a growing billi...

2 months ago - ETF Trends

EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics - AdvisorShares Psychedelics ETF (ARCA:PSIL)

The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space.

2 years ago - Benzinga

Cannabis Is A Psychedelic - Dr. Julie Holland

Dr. Julie Holland on why cannabis is a psychedelic. The biggest risk in psychedelic treatment.

2 years ago - Seeking Alpha

PSIL: When Investing In Psychedelic Firms, ETFs Are The Safer Route

There have been some exciting developments in the research around the medicinal potential of psychedelic compounds. Despite a potential opportunity for disruption, investors should keenly understand t...

2 years ago - Seeking Alpha

The Growth Potential Of Psychedelics Stocks And ETFs

On July 13, 2022, two amendments passed in the House of Representatives that would provide psychedelic drug treatment to veterans and active duty service members. A documentary based on Michael Pollan...

Other symbols: ATAICMPSCYBNMNMD
3 years ago - Seeking Alpha